miércoles, 31 de octubre de 2018

Five burning questions ahead of Sage Therapeutics' date with the FDA - STAT

Five burning questions ahead of Sage Therapeutics' date with the FDA - STAT

Daily Recap

STAT Plus: Five burning questions ahead of Sage Therapeutics’ date with the FDA

By DAMIAN GARDE


ADOBE
Sage's treatment for postpartum depression is not without outstanding questions. Here's a look at the unknowns.

No hay comentarios: